Loading company…
Seattle-based provider of clinical software for glycemic management, with the CORES Platform integrating into EHR systems.
TransformativeMed develops the CORES Platform, a clinician-designed tool for glycemic management that integrates with electronic health record systems. It offers specialty-specific worklists, automated insulin dosing protocols, real-time notifications and decision support for pre-rounding, rounding and discharge planning, sold on subscription to hospitals and medical practices. Founded in 2011 and based in Seattle, US, the company raised USD 5.8 mn in Series A funding in May 2019, led by Alliance of Angels.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in